Form 4 holding
Former CEO, Director
Oncocyte Corp
- Security class
- Common Stock, no par value
- Shares / value
- 583,212
- Estimated value
- $125,332
- Report date
- 01 Dec 2022
- Price
- $0.2149
- Ownership
- Direct
Ronald Asbury Andrews - Former CEO, Director at Insight Molecular Diagnostics Inc.
Issuer-level insider activity
- Role
- Former CEO, Director
- Issuer ticker
- IMDX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Ronald Asbury Andrews since 21 Sep 2025
Reported holdings for Ronald Asbury Andrews in Insight Molecular Diagnostics Inc.
Form 4 holding
Former CEO, Director
Oncocyte Corp
- Security class
- Option to Purchase Common Stock
- Shares / value
- 50,000
- Estimated value
- Report date
- 07 Dec 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Former CEO, Director
Oncocyte Corp
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- Report date
- 01 Dec 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Ronald Asbury Andrews in Insight Molecular Diagnostics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.